The minor changes of muscle quality markers myosin and α-actin expression between the patient and the control groups are less likely to be involved in CDH pathogenesis, while the variable dystrophin expression in both the CDH patient and the controls seems to manifest itself more due to the diaphragm development processes involving apoptosis in muscle mass. This evidence concerns the gene MYH14 and congenital diaphragmatic hernia.